“In first phase of the trial, everything was smooth going and we hope in the second phase it will also be smooth going. Bharat Biotech has been given permission for conducting phase-3 human clinical trials of Covaxin from Drugs Controller General of India (DCGI). Also read Bharat Biotech bosses discuss Covaxin status with Vice-President“Second phase trial for Covaxin will start from Saturday. Over 1700 volunteers have been given dose in first phase and all will be given the second dose,” PCMS and Research Centre dean Dr Anil Kumar Dixit said. Also read Covaxin efficacy can be determined after second dose: Bharat Biotech issues statement after Vij tests positiveAfter that, they were monitored for 28 days and then they are being subjected to the second dose.

Source: dna December 26, 2020 11:15 UTC